A large biomarker associated with chorioamnionitis, and premature rupture of membranes is the increase of MMP‐9, a gelatinase enzyme with the capacity to degrade different components of the robust extracellular matrix of fetal membranes. This evidence concerns the gene MMP9 and chorioamnionitis.